140亿港元嘉兴药厂,17亿元买下新加坡资产

21世纪经济报道
Apr 09

记者丨韩璐鄢子为  嘉兴一家创新药企,海外落下一子。  4月8日,云顶新耀董事会主席吴以芳宣布,拟收购一家新加坡企业,交易总价约为17亿元人民币。  标的,为海森生物子公司。  云顶新耀方面告诉《21CBR》记者,交易完成后,将取得海森新加坡在亚太的14款慢病成熟产品及商业化团队,同时可将国内产品拓展至亚太地区。  2025年,云顶新耀收入为17亿元,增长一倍多。其也定下新目标,2030年营收突破...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10